United States generic drugs market is expected to grow at a significant rate during the forecast period. Generic drugs contain the active ingredients same as existing branded drug. Active ingredient are chemical substances that carries the effect of medication. Generic drugs are in high demand as they are much cheaper than the branded drugs as they do not need to account for high development cost of medicines and associated research activities. Supportive government policies which are promoting the manufacturing of alternative generic drugs and make them available to patients, as they aid in bringing down the healthcare costs. Strong economic position of the United States and well-developed healthcare infrastructure is boosting the growth of the generic drugs market. Increasing prevalence of chronic diseases and the need for effective treatment is fueling the generic drugs demand in United States. Large availability of generics drug gives patient easy access to choose any of the alternatives which is the major reason for lower abandonment of prescription drugs. Raise in awareness among the patients regarding the benefits of healthy lifestyle and early diagnosis and treatment is fostering the demand for generic drugs in United States.

United States generic drugs market is segmented into type, mode of drug delivery, form, source, distribution channel, application, regional distribution, and company. Based on distribution channel, generic drugs market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment is expected to account for major market share for the forecast period, 2022-2026. Presence and development of healthcare facilities and huge patient in-flow into the hospitals is driving factor for high demand of generic drugs in hospital pharmacies. Favorable reimbursement policies and presence of disposable income to afford medical treatment is aiding to increase the generic drug market growth.

The major players operating in the United States generic drugs market are Pfizer Inc., Abbott Laboratories, Inc., Teva Pharmaceuticals USA, Inc., Eli Lilly and Company, Sandoz US, Sun Pharma Inc., Par Pharmaceutical Companies, Inc., Endo Pharmaceuticals Inc, Lupin Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze the historical growth of the market size of United States generic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of United States generic drugs market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast United States generic drugs market based on type, mode of drug delivery, form, source, distribution channel, application, regional distribution, and company.
  • To identify dominant region or segment in the United States generic drugs.
  • To identify drivers and challenges for United States generic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States generic drugs market.
  • To identify and analyze the profile of leading players operating in United States generic drugs market.
  • To identify key sustainable strategies adopted by market players in United States generic drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of United States generic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Generic drugs device manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances related to generic drugs market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United States generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         United States Generic Drugs Market, By Type:

    • Small Molecule Generics
    • Biosimilars
  • United States Generic Drugs Market, By Mode of Drug Delivery:
    • Oral
    • Topical
    • Parenteral
    • Others
  • United States Generic Drugs Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • United States Generic Drugs Market, By Source:
    • In House
    • Contract Manufacturing Organizations
  • United States Generic Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • United States Generic Drugs Market, By Application:
    • Cardiovascular Disease
    • Diabetes
    • Neurology
    • Oncology
    • Anti-Inflammatory Diseases
    • Others
  • United States Generic Drugs Market, By Region:
    • South
    • West
    • Mid-West
    • North East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United States generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
United States generic drugs market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United States Generic Drugs Market

4.    Voice of Customer

5.    Executive Summary

6.    United States Generic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Small Molecule Generics v/s Biosimilars)

6.2.2.     By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.3.     By Form (Tablet, Capsule, Injection, Others)

6.2.4.     By Source (In House v/s Contract Manufacturing Organizations)

6.2.5.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)

6.2.6.     By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.7.     By Company (2020)

6.2.8.     By Region

6.3.  Product Market Map

7.    United States Small Molecule Generic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Mode of Drug Delivery

7.2.2.     By Form

7.2.3.     By Source

7.2.4.     By Distribution Channel

7.2.5.     By Application

8.    United States Biosimilar Generic Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Mode of Drug Delivery

8.2.2.     By Form

8.2.3.     By Source

8.2.4.     By Distribution Channel

8.2.5.     By Application

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  United States Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Pfizer Inc.

13.2.2.  Abbott Laboratories, Inc.

13.2.3.  Teva Pharmaceuticals USA, Inc.

13.2.4.  Eli Lilly and Company

13.2.5.  Sandoz US

13.2.6.  Sun Pharma Inc.

13.2.7.  Par Pharmaceutical Companies, Inc.

13.2.8.  Endo Pharmaceuticals Inc

13.2.9.  Lupin Pharmaceuticals, Inc.

13.2.10.                Aurobindo Pharma USA, Inc.

14.  Strategic Recommendations

15. About Us & Disclaimer